Physician profile
David Oselinsky
NPI 1639158173
$2,655.53
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $268 · 2021: $673 · 2022: $540 · 2023: $645 · 2024: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $789.19 | 2019-2023 | Myrbetriq |
| Abbvie INC. | $644.05 | 2021-2024 | |
| Janssen Biotech, INC. | $272.79 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $170.29 | 2019-2023 | Xiaflex, Aveed |
| Allergan, INC. | $168.04 | 2019-2022 | |
| Urogen Pharma, INC. | $131.09 | 2023-2024 | Jelmyto |
| Pfizer INC. | $87.42 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $76.75 | 2023 | Gemtesa |
| Karl Storz Endoscopy-America | $58.38 | 2022-2023 | N.A. |
| Coloplast Corp | $40.57 | 2021 | |
| Janssen Scientific Affairs, LLC | $35.72 | 2019 | |
| Myovant Sciences INC. | $28.87 | 2021-2022 | |
| Urovant Sciences INC | $25.75 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $24.78 | 2022 | |
| 180 Medical, INC. | $19.46 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $19.31 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.04 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $15.49 | 2021 | |
| Dentsply Ih INC. | $15.38 | 2019 | |
| Merck Sharp & Dohme LLC | $13.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Oselinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.